Compare INAB & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INAB | MTR |
|---|---|---|
| Founded | 2016 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 8.6M |
| IPO Year | 2021 | N/A |
| Metric | INAB | MTR |
|---|---|---|
| Price | $1.68 | $4.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $108.00 | N/A |
| AVG Volume (30 Days) | ★ 51.5K | 2.7K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.44% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $623,288.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.75 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.53 | $4.29 |
| 52 Week High | $12.53 | $10.42 |
| Indicator | INAB | MTR |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 51.36 |
| Support Level | $1.73 | $4.58 |
| Resistance Level | $1.80 | $4.80 |
| Average True Range (ATR) | 0.13 | 0.11 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 2.28 | 63.91 |
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.